Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Sensors (Basel, Switzerland)
|
November 2, 2019
Measuring Spatial and Temporal PM<sub>2.5</sub> Variations in Sacramento, California, Communities Using a Network of Low-Cost Sensors
Anondo Mukherjee, Steven G Brown, Michael C McCarthy, et al.
Antimicrobial Agents and Chemotherapy
|
July 14, 2001
Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole
L J Wheat, G Cloud, P C Johnson, et al.
Journal of the American College of Nutrition
|
April 4, 2006
Association between carbohydrate intake and serum lipids
Yunsheng Ma, Youfu Li, David E Chiriboga, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
October 10, 2006
Low-carbohydrate and high-fat intake among adult patients with poorly controlled type 2 diabetes mellitus
Yunsheng Ma, Barbara C Olendzki, Andrea R Hafner, et al.
The Journal of Infectious Diseases
|
January 1, 1996
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group
C Leport, G Chêne, P Morlat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 1997
Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group
F Rousseau, S Pueyo, P Morlat, et al.
Controlled Clinical Trials
|
June 10, 1998
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group
G Chêne, P Morlat, C Leport, et al.
The New England Journal of Medicine
|
September 30, 1993
Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team
B J Luft, R Hafner, A H Korzun, et al.
The Journal of Infectious Diseases
|
February 1, 1994
Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS
M A Jacobson, C L Besch, C Child, et al.
European Journal of Clinical Nutrition
|
May 19, 2006
PDA-assisted low glycemic index dietary intervention for type II diabetes: a pilot study
Y Ma, B C Olendzki, D Chiriboga, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Sensors (Basel, Switzerland)
|
November 2, 2019
Measuring Spatial and Temporal PM<sub>2.5</sub> Variations in Sacramento, California, Communities Using a Network of Low-Cost Sensors
Anondo Mukherjee, Steven G Brown, Michael C McCarthy, et al.
Antimicrobial Agents and Chemotherapy
|
July 14, 2001
Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole
L J Wheat, G Cloud, P C Johnson, et al.
Journal of the American College of Nutrition
|
April 4, 2006
Association between carbohydrate intake and serum lipids
Yunsheng Ma, Youfu Li, David E Chiriboga, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
October 10, 2006
Low-carbohydrate and high-fat intake among adult patients with poorly controlled type 2 diabetes mellitus
Yunsheng Ma, Barbara C Olendzki, Andrea R Hafner, et al.
The Journal of Infectious Diseases
|
January 1, 1996
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group
C Leport, G Chêne, P Morlat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 1997
Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group
F Rousseau, S Pueyo, P Morlat, et al.
Controlled Clinical Trials
|
June 10, 1998
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group
G Chêne, P Morlat, C Leport, et al.
The New England Journal of Medicine
|
September 30, 1993
Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team
B J Luft, R Hafner, A H Korzun, et al.
The Journal of Infectious Diseases
|
February 1, 1994
Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS
M A Jacobson, C L Besch, C Child, et al.
European Journal of Clinical Nutrition
|
May 19, 2006
PDA-assisted low glycemic index dietary intervention for type II diabetes: a pilot study
Y Ma, B C Olendzki, D Chiriboga, et al.
Page
of 8